Search Results - Mary M. Horowitz

Mary M. Horowitz

Mary M. Horowitz is an American oncologist who specializes in blood and marrow transplants. Provided by Wikipedia
  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703

    Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703 by Sameem Abedin, Michael J. Martens, Javier Bolaños-Meade, Monzr M. Al Malki, Qinghua Lian, Lyndsey Runaas, Hany Elmariah, Mahasweta Gooptu, Karilyn T. Larkin, Brian C. Shaffer, Alison W. Loren, Melhem Solh, Amin M. Alousi, Omer H. Jamy, Miguel-Angel Perales, Andrew Rezvani, Ami Bhatt, Najla El Jurdi, Janny M. Yao, Kristy Applegate, Leslie S. Kean, Yvonne A. Efebera, Ran Reshef, William Clark, Eric Leifer, Wael Saber, Mary M. Horowitz, Richard J. Jones, Shernan G. Holtan, Mehdi Hamadani

    Published 2025-07-01

    Abstract: Allogeneic hematopoietic cell transplant (allo-HCT) is underutilized in adults aged ≥70 years. Morbidity, often driven by graft-versus-host disease (GVHD), is considered a major barrier to its use. The BMT CTN 1703 trial (ClinicalTrials.gov identifier: NCT03959241) randomly assigned adults...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

    Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704 by Mohamed L. Sorror, Wael Saber, Brent Logan, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Lori Jarrett, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R. McCurdy, Lawrence E. Morris, Philip H. Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca Olin, Joseph Maakaron, Ronald Sobecks, Sarah A. Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew S. Artz

    Published 2025-07-01

    Abstract: Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for older adults with hematologic malignancies. Concerns on nonrelapse mortality (NRM) in older adults limit allo-HCT utilization. We executed a prospective, observational study BMT-CTN 1704 (Blood and Marrow...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: